Health and Fitness Health and Fitness
Thu, May 10, 2012
Wed, May 9, 2012
Tue, May 8, 2012
Mon, May 7, 2012
Sat, May 5, 2012
Fri, May 4, 2012
Thu, May 3, 2012
[ Thu, May 03rd 2012 ] - Market Wire
00 p.m. EDT
Wed, May 2, 2012
[ Wed, May 02nd 2012 ] - Market Wire
Location Change
Tue, May 1, 2012
Mon, April 30, 2012
[ Mon, Apr 30th 2012 ] - Market Wire
Hologic to Acquire Gen-Probe
Sun, April 29, 2012
Sat, April 28, 2012
Fri, April 27, 2012
Thu, April 26, 2012

Prima BioMed to Present at the 37th Annual Deutsche Health Care Conference


//health-fitness.news-articles.net/content/2012/ .. 37th-annual-deutsche-health-care-conference.html
Published in Health and Fitness on Thursday, May 3rd 2012 at 4:36 GMT by Market Wire   Print publication without navigation


May 03, 2012 07:30 ET

Prima BioMed to Present at the 37th Annual Deutsche Health Care Conference

SYDNEY, AUSTRALIA--(Marketwire - May 3, 2012) - Prima BioMed Ltd (NASDAQ: [ PBMD ]) (ASX: PRR) announced today that Dr. Neil Frazer, Chief Medical Officer, will present at the Deutsche Health Care Conference on Tuesday, May 8, 2012 at 8:40am Eastern Time in Boston, MA. Dr. Frazer will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Prima BioMed's website at [ http://www.primabiomed.com.au/investor/presentations.php ]. A replay of the webcast will be available for 10 business days following the presentation.

About Prima BioMed
Prima BioMed is a NASDAQ and ASX and listed Australian health care company. The Company is focused on technologies in the fields of cancer immunotherapy and immunology.

Prima's lead product is the CVac ovarian cancer therapy treatment. CVac has completed two successful clinical trials and is progressing advanced clinical development in the United States, Australia, and Europe.

The Company's broader, long term goal is to develop cancer treatment technologies and programs for global markets.



Publication Contributing Sources